awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33638830-5A47613F-FB6F-48B6-9826-6DBC07BB03F2
Q33638830-5A47613F-FB6F-48B6-9826-6DBC07BB03F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33638830-5A47613F-FB6F-48B6-9826-6DBC07BB03F2
Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.
P2860
Q33638830-5A47613F-FB6F-48B6-9826-6DBC07BB03F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33638830-5A47613F-FB6F-48B6-9826-6DBC07BB03F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5fb794ea2e9790e1f80c93ca375e3205167844b1
P2860
Development of a rapid and sensitive LC-MS/MS assay for the determination of sorafenib in human plasma.